These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 17297531

  • 1. Attitude of Physicians towards the Management of Bone Disease in Hemodialysis Patients: A Questionnaire Based Survey.
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2006 Mar; 17(1):10-8. PubMed ID: 17297531
    [Abstract] [Full Text] [Related]

  • 2. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [Abstract] [Full Text] [Related]

  • 3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jan; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 5. Attitude of physicians towards the follow-up of renal transplant patients: a questionnaire survey in Saudi Arabia.
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):159-67. PubMed ID: 16903621
    [Abstract] [Full Text] [Related]

  • 6. The attitude of physicians towards education and rehabilitation of patients on chronic dialysis: a questionnaire survey.
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):526-34. PubMed ID: 17186688
    [Abstract] [Full Text] [Related]

  • 7. Attitude of physicians in Saudi Arabia towards anemia treatment strategies in patients with chronic kidney disease.
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):65-72. PubMed ID: 17237894
    [Abstract] [Full Text] [Related]

  • 8. Survey of the attitude of physicians towards establishing and maintaining a peritoneal dialysis program.
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):355-64. PubMed ID: 16970256
    [Abstract] [Full Text] [Related]

  • 9. Survey of attitude of physicians on updates in the management of anemia in chronic kidney disease patients.
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):410-6. PubMed ID: 19414943
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
    Lucchi L, Carboni C, Stipo L, Malaguti V, Ferrari F, Graziani R, Arletti S, Graziosi C.
    Artif Organs; 2011 Dec; 35(12):1186-93. PubMed ID: 21848793
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    Van Buren PN, Lewis JB, Dwyer JP, Greene T, Middleton J, Sika M, Umanath K, Abraham JD, Arfeen SS, Bowline IG, Chernin G, Fadem SZ, Goral S, Koury M, Sinsakul MV, Weiner DE, Collaborative Study Group.
    Am J Kidney Dis; 2015 Sep; 66(3):479-88. PubMed ID: 25958079
    [Abstract] [Full Text] [Related]

  • 15. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
    Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA.
    Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
    [Abstract] [Full Text] [Related]

  • 16. The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey.
    Martin CJ, Reams SM.
    J Ren Nutr; 2003 Apr; 13(2):133-6. PubMed ID: 12671837
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 Apr; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 19. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H, Sato T, Kurihara T, Kurosawa T, Fukagawa M.
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [Abstract] [Full Text] [Related]

  • 20. RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group.
    Slatopolsky EA, Burke SK, Dillon MA.
    Kidney Int; 1999 Jan; 55(1):299-307. PubMed ID: 9893140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.